H

Cellyan Biotechnology Co., Ltd

HKPD Nasdaq Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries Kowloon, Hong Kong www.9zt.hk
$0.12
Mkt Cap 1.9M
Our Corporate History Cellyan Biotechnology, an exempted company established under the laws of Cayman Islands on August 17, 2023, has three subsidiaries: (i) V-Alliance Technology Supplies Limited, es…

Our Corporate History Cellyan Biotechnology, an exempted company established under the laws of Cayman Islands on August 17, 2023, has three subsidiaries: (i) V-Alliance Technology Supplies Limited, established under the laws of Hong Kong on September 1, 2016, and (ii) Joint Cross Border Logistics Company Limited, previously known as Eternal Profits Limited, and established under the laws of Hong Kong on July 18, 2017. Pre-IPO Restructuring Upon Cellyan Biotechnology’s incorporation on August 17, 2023, it had an authorized share capital of $50,000 divided into 50,000,000 ordinary shares of a single class, par value $0.001 per share. Upon incorporation, ten ordinary shares were allotted and issued to the initial subscriber, Ascentium (Cayman) Limited (f.k.a. Harneys Fiduciary (Cayman) Limited), which transferred the single ordinary share to Lap Sun Wong, on the same day. 34 On December 1, 2023, an additional 9,500,990 ordinary shares in total, par value $0.001 each, were allotted and issued to Lap Sun Wong and new shareholders, including among others, 1,710,170 ordinary shares to Lap Sun Wong; 4,448,520 ordinary shares to Fame Overseas Supply Chain Limited; 190,020 ordinary shares to Profit Seeker Limited; 617,850 ordinary shares to Pacific Health Century International Group Limited; and 617,850 ordinary shares to Atlantic Health Century International Group Limited.

/100 Overall
Calculating score…
Running full analysis
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$18.2M
FCF TTM
$432.6K
P/E RATIO
1.9x
P/FCF
4.4x
Running full 6-factor analysis…